For research use only. Not for use in humans.

Recaticimab (Anti-PCSK9)

Synonyms: SHR-1209 Cat.No.A3023

Recaticimab (Anti-PCSK9) is a humanized monoclonal antibody that targets PCSK9. It has potential application in hypercholesterolemia. MW :148.28 KD

Recaticimab (Anti-PCSK9)

Quality Control

Specificity

Name	Citation	PCSK9
PF-06446846	0	+++
PF-06446846 hydrochloride	0	✔
SBC-110736	0	✔
R-IMPP	0	✔
SBC-115076	9	✔

Expand to Check More

1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description	Recaticimab (Anti-PCSK9) is a humanized monoclonal antibody that targets PCSK9. It has potential application in hypercholesterolemia. MW :148.28 KD
References	[1] https://pubmed.ncbi.nlm.nih.gov/35039035/

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	2361290-85-7
Isotype	Human IgG1
Source	CHO
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.